Neuropsychopharmacology
- FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens1 month ago
- Cortical myelin mapping in antipsychotic medication-naïve, first-episode psychosis patients1 month ago
- The Tailtag: A multi-mouse tracking system to measure social dynamics in complex environments1 month ago
- DLPFC: The Decade circLe CCNP Family Cohort1 month ago
- Stress-related genetic factors modify the effect of socioeconomic status on cardiovascular risk1 month ago
- The efficacy of elevating anandamide via inhibition of fatty acid amide hydrolase (FAAH) combined with internet-delivered cognitive behavioral therapy in the treatment of post-traumatic stress disorder: a randomized, placebo-controlled clinical trial2 months ago
- Sleep patterns predicting stress resilience are dependent on sex2 months ago
Journal of Psychopharmacology
- Corrigendum: Is psychedelic use associated with cancer? Interrogating a half-century-old claim using contemporary population-level data2 months ago
- Retraction: The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis2 months ago
- Circadian rhythmicity in prepulse inhibition of the acoustic startle response: A study of chronotype and time-of-day effects in young healthy adults2 months ago
- CYP1A2 genotype-dependent effects of smoking on mirtazapine serum concentrations2 months ago
- Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review2 months ago
- The effects of menthol content on the abuse liability of smokeless tobacco in a randomized crossover trial2 months ago
- Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder2 months ago
European Neuropsychopharmacology
- Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov3 months ago
- Creatine as a treatment for depression: A brain bioenergetics perspective3 months ago
- Rethinking suicide prediction: From static risk factors to dynamic models3 months ago
- Commentary on the Article “Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality”3 months ago
- Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort3 months ago
- Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study3 months ago
- Negative Symptoms in Schizophrenia: The Placebo Effect as a Barrier to Drug Development?3 months ago